comprehensive -WSS

comprehensive

author：focus 2025-08-12 08:30:05 - browse：59

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： AstraZeneca to buy developer of next

WSS

Gene editing the human germline: What are the risks?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Should insurance cover cosmetic surgery?

Argenx readies a blockbuster opportunity with drug for autoimmune disease

J&J reports mixed data on next

Decentralized clinical trials need collaboration to achieve wider use

hotspot

comprehensive

leisure time

Medicare details structure of new drug price negotiation program

J&J reports mixed data on next

New air purifier tech could be key to improving indoor air quality

New research sheds light on how often breast cancer is overdiagnosed

Cancer drug shortages should be causing more outrage

Should insurance cover cosmetic surgery?

Supreme Court strikes down use of affirmative action

Nurses recount patients attacks

Continuity nursing helped my family in our darkest PICU moments

U.K. researchers warn about biases in medical devices, algorithms

explore

Intermittent fasting comes with a heart risk? Not so fast

Health AI adoption puts security, privacy startups on investors' radar

Stroke rates rising, especially in working

Protect nursing home residents from future pandemics

The world needs the new pandemic treaty

Stroke rates rising, especially in working

hotspot

focus

hotspot

entertainment